Published in Arch Dermatol on February 01, 1973
The etiology and molecular genetics of human pigmentation disorders. Wiley Interdiscip Rev Dev Biol (2012) 0.87
Premature cataracts associated with generalized lentigo. Trans Am Ophthalmol Soc (1979) 0.75
Mitral valve prolapse and lentiginosis profusa. J Natl Med Assoc (1981) 0.75
Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol (1983) 2.65
Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J Exp Med (1986) 2.62
Successful culture of adult human melanocytes obtained from normal and vitiligo donors. J Invest Dermatol (1990) 2.31
Use of fine art to enhance visual diagnostic skills. JAMA (2001) 2.24
Studies on the origin of human leukocytic pyrogen. J Exp Med (1970) 2.22
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20
On the etiology of vitiligo and gray hair. Am J Med (1971) 1.88
Factors affecting the quantitative production and assay of human leukocytic pyrogen. J Lab Clin Med (1970) 1.86
Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angitis. J Invest Dermatol (1975) 1.81
Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol (1983) 1.71
Purification and characterization of a calmodulin-dependent kinase from rat brain cytosol able to phosphorylate tubulin and microtubule-associated proteins. J Biol Chem (1983) 1.69
Dermatosparaxis in children. A case report and review of the newly recognized phenotype. Arch Dermatol (1993) 1.69
Five cases of calciphylaxis and a review of the literature. J Am Acad Dermatol (1999) 1.68
Action of light on frog pigment cells in culture. Pigment Cell Res (1990) 1.66
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Basement membrane and fibroblast aberration in blisters at the donor, graft, and spontaneously healed sites in patients with burns. Arch Dermatol (1992) 1.63
Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am J Hum Genet (1996) 1.59
Normal murine melanocytes in culture. In Vitro Cell Dev Biol (1987) 1.47
Identification of the major postsynaptic density protein as homologous with the major calmodulin-binding subunit of a calmodulin-dependent protein kinase. J Neurochem (1984) 1.44
Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.44
Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol (1983) 1.42
Inhibition of biologic activity of poly I: poly C by human plasma. Proc Soc Exp Biol Med (1970) 1.42
Human melanocytes cultured from nevi and melanomas. J Invest Dermatol (1986) 1.36
Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet (1994) 1.35
Association of cell surface receptors for melanotropin with the Golgi region in mouse melanoma cells. Proc Natl Acad Sci U S A (1976) 1.35
Study of autoimmune disease in New Zealand mice. I. Genetic features and natural history of NZB, NZY and NZW strains and NZB-NZW hybrids. J Invest Dermatol (1968) 1.34
The use of temperature sensitivity and selective cell culture systems for differentiation of herpes simplex virus types 1 and 2 in a clinical laboratory. Proc Soc Exp Biol Med (1977) 1.33
Regulation of melanocyte stimulating hormone action at the receptor level: discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle. Proc Natl Acad Sci U S A (1974) 1.33
5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature (1978) 1.31
Ultrastructure of the human dermal microcirculation. II. The capillary loops of the dermal papillae. J Invest Dermatol (1977) 1.29
Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol (1997) 1.26
Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol (1991) 1.26
Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol (1982) 1.25
Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. Am J Hum Genet (1992) 1.25
Studies in cutaneous aging: I. The elastic fiber network. J Invest Dermatol (1982) 1.25
Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest (1989) 1.22
Pattern of familial aggregation of vitiligo. Arch Dermatol (1993) 1.21
Vitiligo. What is it? Is it important? JAMA (1978) 1.21
A mouse model for vitiligo. J Invest Dermatol (1986) 1.19
Ultrastructure of the human dermal microcirculation: the horizontal plexus of the papillary dermis. J Invest Dermatol (1976) 1.17
Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol (1977) 1.15
Isotretinoin treatment of Darier's disease. J Am Acad Dermatol (1982) 1.13
The distribution of melanocytes in the leptomeninges of the human brain. J Invest Dermatol (1984) 1.12
The effects of ultraviolet light and certain drugs on La-bearing Langerhans cells in murine epidermis. Cell Immunol (1981) 1.11
Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol (1982) 1.10
Microcirculation in psoriatic skin. J Invest Dermatol (1974) 1.09
Transplantation of human melanocytes. J Invest Dermatol (1987) 1.09
Tyrosinases of murine melanocytes with mutations at the albino locus. Proc Natl Acad Sci U S A (1988) 1.08
Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases. J Invest Dermatol (1983) 1.08
Tyrosinase activity and abundance in Cloudman melanoma cells. Arch Biochem Biophys (1984) 1.07
Activation of epidermal tyrosinase. Biochem Biophys Res Commun (1970) 1.06
Three-dimensional reconstruction of endothelial cell gaps in psoriatic vessels and their morphologic identity with gaps produced by the intradermal injection of histamine. J Invest Dermatol (1986) 1.05
Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res (1985) 1.05
Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol (1991) 1.04
White spots in tuberous sclerosis. J Pediatr (1970) 1.04
The effect of vitiligo on sexual relationships. J Am Acad Dermatol (1990) 1.03
On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes. Lab Invest (1994) 1.02
Waardenburg's syndrome with Hirschsprung's disease: a neural crest defect. Pediatr Dermatol (1986) 1.01
Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone. Proc Natl Acad Sci U S A (1975) 1.01
Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus (2004) 1.01
Splenic regulation of the clinical appearance of small tumors. J Immunol (1975) 0.99
Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol (1982) 0.99
Vitiligo: the loss of pigment in skin, hair and eyes. J Dermatol (1978) 0.99
A study of the veil cells around normal, diabetic, and aged cutaneous microvessels. J Invest Dermatol (1986) 0.99
In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins. Cancer Res (1987) 0.98
Annulus migrans. Identical lesions in pustular psoriasis, Reiter's syndrome, and geographic tongue. Arch Dermatol (1973) 0.98
New observations on vitiligo and ocular disease. Am J Ophthalmol (1983) 0.98
The biochemistry of melanotropic agents. Pharmacol Rev (1967) 0.98
Progression of pigmented purpura-like eruptions to mycosis fungoides: report of three cases. J Am Acad Dermatol (1988) 0.97
Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic mice. J Invest Dermatol (1993) 0.97
Ocular abnormalities occurring with vitiligo. Ophthalmology (1979) 0.97
Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res (1998) 0.96
The dual effect of melanocyte-stimulating hormone (MSH) on the growth of cultured mouse melanoma cells. Exp Cell Res (1977) 0.96
Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res (1997) 0.95
Vitiligo. It is important. Arch Dermatol (1982) 0.95
Racemization of alpha-melanotropin. Biochim Biophys Acta (1971) 0.94
The MAGIC syndrome (mouth and genital ulcers with inflamed cartilage). Arch Dermatol (1990) 0.94
Ultrastructure of the human dermal microcirculation. III. The vessels in the mid- and lower dermis and subcutaneous fat. J Invest Dermatol (1981) 0.94
Complex effects of antibodies to polypeptide hormones. J Clin Endocrinol Metab (1970) 0.93
The effect of chlorpromazine on oculocutaneous pigmentation in the guinea pig. J Invest Dermatol (1967) 0.93
Pigment cell transplantation for treatment of vitiligo: a progress report. J Am Acad Dermatol (1994) 0.93
Vitiligo. J Am Acad Dermatol (1984) 0.93
Three-dimensional reconstructions of objects from serial sections using a microcomputer graphics system. J Invest Dermatol (1986) 0.93
Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry (1979) 0.93
Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens. J Cell Physiol (1992) 0.92
Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol (1989) 0.92
A proteolytically activated tyrosinase from frog epidermis. J Biol Chem (1974) 0.92
Tyrosinase and inhibition of proliferation of melanoma cells and fibroblasts. Exp Cell Res (1977) 0.92
The prevalence of vitiligo and poliosis in patients with uveitis. J Am Acad Dermatol (1981) 0.92